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Abstract Empirical evidence suggests that people are
fairly sensitive to cost sharing arrangements in ambulatory
mental healthcare. However, pure cost sharing effects are
typically hard to measure due to the presence of adverse
selection effects. In this paper, we examine the impact of
cost sharing on mental healthcare utilization in the context
of mandatory health insurance where adverse selection is
absent. Using a large proprietary dataset of a Dutch private
health insurer, we examine to what extent a new copay-
ment scheme for adult mental healthcare changed health-
care utilization. We exploit the fact that non-adults are
exempted from copayments. First, we compare changes in
utilization among adults and non-adults using t tests and a
difference-in-difference analysis. Second, we highlight
differential changes in mental healthcare utilization by
treatment (duration and type of mental illness) and indi-
vidual characteristics (gender and socioeconomic status).
Third, we evaluate to what extent anticipatory behavior
occurred pending the introduction and subsequent repeal of
the new copayment scheme. Our results show a strong and
significant (p\ 0.01) decrease in outpatient secondary
mental healthcare utilization among adults following the
introduction of copayments, which is absent among non-
adults. This decrease is concentrated among treatments for
less severe mental illnesses. Furthermore, the utilization
patterns suggest the presence of anticipatory behavior.
Keywords Health insurance  Cost sharing  Copayments 
Healthcare utilization  Mental healthcare  Natural
experiment
JEL Classification D12  I13
Introduction
The effects of cost sharing seem particularly strong for
mental healthcare. Specifically, Frank andMcGuire [1] show
that ‘nearly all the available evidence, experimental or
observational, points in the direction of greater price
response for ambulatory [outpatient] mental health than
other healthcare services’ (p. 911). Yet, with the exception of
the RAND Health Insurance Experiment (HIE) [2], such
observational research is subject to adverse selection [3].
Adverse selection likely leads to an underestimation of price
responses for the population at large; when individuals can
freely decide on the level of insurance coverage, healthy
people aremore likely to choose higher levels of cost sharing
for which their response may be relatively small. Further-
more, evidence of price responses for mental healthcare
outside the US is still mostly indirect and mainly comprises
research on under- and overtreatment of mental disorders,
rather than on price responses per se [4]. In contrast, this
paper aims to investigate the pure copayment effects (i.e.,
without adverse selection effects) for outpatient mental
healthcare in a non-US context where adverse selection does
not play a role due to both mandatory health insurance and
mandatory copayments. This is especially relevant as the
benefits of copayments within Europe are increasingly being
questioned by both scholars (e.g., [5]) and policy-makers [6].
In addition, this paper contributes to existing knowledge
in two other ways. First, by estimating the differential
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impact of price on mental healthcare utilization by type of
treatment, by gender, and by socioeconomic status, we
contribute to the limited knowledge in this area. This is
relevant because other studies indicate that particularly
males and people with lower socioeconomic status are
vulnerable to underutilization of mental health services [7].
Second, we examine whether people anticipate changes in
copayments. Evidence on anticipatory behavior is limited,
because most research is either survey-based [8–10] or
prone to adverse selection effects [3]. Moreover, a recent
empirical study shows that anticipatory behavior is
important for an appropriate evaluation of the effect of cost
sharing [11].
This research utilizes changes of copayments in the
Dutch universal mandatory health insurance scheme to
analyze price responsiveness for mental healthcare. In
2012, existing copayments for primary mental healthcare
were raised and new copayments were introduced for
secondary mental healthcare in the Netherlands. Using a
large proprietary dataset of a private Dutch health insurer,
we are able to examine the pure effect of these changes for
outpatient mental healthcare. We do so by comparing
changes in healthcare utilization between those who are
affected by these changes in copayments (adults) and those
who are not affected (non-adults).
In sum, the goal of this paper is threefold and consists
of: (1) estimating the pure demand response for outpatient
mental health services, net of selection effects and in
another setting than the US; (2) estimating differences in
demand varying with treatment, gender, and socioeco-
nomic status; and (3) evaluating the occurrence of antici-
patory behavior in response to changes in cost sharing
regime.
Previous research
Economic theory predicts that people use fewer mental
healthcare services when cost sharing is introduced or
increased in their insurance coverage. The magnitude of
decreases in healthcare utilization depends on the extent of
cost sharing and the elasticity of demand. The RAND HIE
found a price elasticity of general healthcare between –0.10
and –0.14 for coinsurance rates between 0–25 and 25–95%,
respectively [12]. Other research reported similar results in
various countries and at various points in time [1, 13].
Research focusing specifically on outpatient mental
healthcare suggests that the price elasticity of such care is
larger than that of general medical care, as scholars found
price elasticities of -0.79 and -0.31, respectively, for
coinsurance rates between 25 and 95% [2]. Research in the
Netherlands delivered similar results with price elasticities
of -0.14 for cost sharing arrangements in general health-
care [14]. These elasticities differed greatly between
healthcare services, with a price elasticity of -0.40 for
visits to the general practitioner and -0.08 for prescription
drug and were found to increase with the extent of cost
sharing. Otherwise, most evidence of price effects in
mental healthcare outside the US is still indirect. Notably,
such evidence suggests that receiving a treatment is
strongly associated with disorder severity as well as posi-
tively correlated with age, level of education, and the
female gender [7].
There are three possible explanations for differences in
price elasticities between mental healthcare and other
healthcare services. First, it is argued that elasticities differ
because of the necessity of treatments [14, 15]; it is pre-
sumably easier to forego a visit to a general practitioner for
a minor ache than to forego a visit to the hospital for a
broken leg. In the same way, a mental illness could be
perceived as less acute than that same broken leg and could
hence be easier foregone. Second, the willingness to seek
professional help in mental healthcare is likely restrained
by fears of stigmatization [7]. Third, an increasing number
of people have pessimistic perceptions of the effectiveness
of mental healthcare and sometimes even prefer to wait
until a mental illness fades by itself [16]. Copayments
could interact with and aggravate these tendencies to
undertreat mental disorders and thus lead to differences in
copayment effects vis-a`-vis other healthcare services.
Furthermore, anticipation effects (or ex ante moral
hazard) play a role in shaping responses to cost sharing.
Price responses do not merely embody a binary choice
between using and not using healthcare at a given cost
sharing level. Rather, by adequately timing healthcare
consumption such that healthcare is used when copayments
are lowest, patients can minimize cost sharing. Changes in
insurance coverage that are announced beforehand thus
create opportunities for ex ante moral hazard if healthcare
consumption can be scheduled. A recent study among
employees whose firm discontinued a health plan with
generous first-dollar coverage to only retain a high-de-
ductible health plan for example found that this shift
reduced healthcare utilization by 19% [11]. Yet, when
correcting for anticipatory behavior, only an 11–15%
decrease in healthcare utilization could be attributed to the
high-deductible health plan. Hence, ex ante moral hazard
may increase measured price elasticities in natural exper-
iments by spurring demand prior to the introduction of new
cost sharing arrangements to substitute for expected
demand after that introduction.
Empirical setting
The Dutch healthcare system is characterized by a uni-
versal mandatory basic health insurance scheme, covering
all essential healthcare services with a standardized
T. R. Lambregts, R. C. J. A. van Vliet
123
benefits package for the entire population. Basic health
insurance coverage is offered by private health insurers in
return for a community-rated premium. The basic benefits
package, a mandatory deductible for most healthcare ser-
vices and copayments, are all set by the national
government.
The provision of Dutch mental healthcare can be dis-
tinguished in primary and secondary care. In our study
period, 28% of the mental health patients received primary
care and 77% secondary care [17]. Primary care, which is
accessible without referral, offers treatments for relatively
mild disorders. Secondary care consists of treatments of
more serious conditions that need specialized care. In
secondary mental healthcare, a further distinction can be
made between curative care and long-term—often institu-
tionalized—care. To gain access to secondary mental
healthcare, a referral from a general practitioner or primary
mental healthcare provider is required.
Since 2008, most mental healthcare services have been
included in the basic health insurance, with the exception
of chronic mental disorders and long-term mental health-
care,1 which are insured through a social long-term care
insurance. Coverage for primary mental healthcare had
been limited to eight sessions per year, all subject to a
copayment of €10 per session. The cost sharing reforms,
summarized in Table 1, encompassed both an increase of
existing primary mental healthcare copayments and the
introduction of a new copayment for secondary care. In
primary care, existing copayments were increased from
€10 to €20 per session and the number of sessions covered
in the basic health insurance was reduced from eight to
five. In secondary care, a copayment of €100 per 100 min,
capped at €200 annually was introduced.2 These secondary
care copayments were repealed again at the start of 2013.
Furthermore, the reforms comprised the removal of
adjustment disorders from the basic health insurance ben-
efit package. At the same time, the mandatory deductible
increased by €180 between 2011 and 2013. Finally, non-
adults, constituting 23% of all Dutch mental health patients
between 2011 and 2013 [17], were exempted from paying
any copayments or deductibles between 2011 and 2013.
This exemption hence creates a convenient control group to
analyze the effects of introducing and increasing
copayments.
Data
This study utilizes proprietary anonymized claims data
from a sample of individuals with a basic health insurance
from a Dutch health insurer to analyze the number of
mental healthcare treatments. Individuals in our sample
that were not insured with this insurer for the entire period
between 1 January 2011 and 31 December 2013 have been
excluded in order to form an unvarying cohort. Individuals
that made use of crisis treatments have been excluded from
this sample as well, because such treatments were excluded
from copayments.
In this way, we created a cohort of 324,675 continuously
enrolled individuals. Of these, 78% were adults
(C18 years), 18% non-adults and 4% turned 18 during the
period examined. This latter group has been excluded from
further analysis, since, by turning 18, its individuals shifted
from the control group to the treatment group during the
period analyzed. The adult group consisted of 46% male
and 54% female and for non-adults there was a 50/50
division. Subsequently, we estimated aggregated socioe-
conomic status scores (SES scores)3 of all individuals by
linking their four digit zip codes4 to SES score data of The
Netherlands Institute for Social Research [18]. Hence, we
found average SES scores slightly below the national
average of 2012: -0.12 for non-adults and -0.11 for
adults. The aggregated SES scores were then used to assign
the insured in our sample to a quintile, based on SES scores
in the entire Dutch population. The distribution of indi-
viduals from our sample across these SES quintiles is
summarized in Table 7 (see Appendix). Finally, we verified
that changes in numbers of primary and secondary mental
healthcare visits within our sample are comparable to
national trends [17], signifying the external validity of our
study.
To analyze healthcare utilization, we used so-called
‘diagnosis and treatment combination codes’ (DTC codes)5
and general billing information. Dutch health insurers
register healthcare utilization of their insured through
billing information from healthcare providers. In these
bills, healthcare providers summarize treatments using
1 Long-term mental healthcare treatments include psychiatric insti-
tutionalizations of at least 1 year in duration (at least 3 years in
duration as of January 1, 2015).
2 Exemptions were made for crisis treatments, treatments of invol-
untarily hospitalization and treatments started after so-called inter-
ference care, in which social workers try to persuade worrisome
healthcare avoiders to obtain the healthcare services they need.
3 These aggregated neighborhood SES scores are based on four
neighborhood characteristics: average income, percentage of inhab-
itants with a low income (less than €9250 annually converted to
Dutch price levels of 2000), percentage of low-educated inhabitants
[highest level of completed education is primary education, pre-
vocational education (VMBO) or lower vocational education (MBO-
1)] and percentage of inhabitants without a job. The SES scores reflect
deviations from the national average over the years 1998–2014.
4 Dutch zip codes consist of four numbers and two letters (e.g., 1000
AA) in which the numbers indicate a neighborhood or village and the
letters indicate one or sometimes multiple streets within this area.
5 For a more detailed overview of the system of DTC codes, see [19].
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DTC codes.6 For secondary mental healthcare, DTC codes
include inter alia start and end dates of treatments, the
illness that patients suffered (divided in 15 general diag-
nosis codes based on DSM-IV) and the total duration of the
diagnosis and treatment (in ranges of minutes).7 For pri-
mary mental healthcare, no DTC codes exist and billing
information only provides health insurers with dates of
treatment sessions.
We utilize this data to determine when patients started
their mental healthcare treatment, or initial treatments. For
outpatient secondary mental healthcare, initial treatments
exclude DTC codes that signify an extension of the treat-
ment after 365 days. All other secondary treatments are
considered initial treatments on the billed starting date. As
primary care sessions are billed independently and without
further detail, it is often unclear whether a consultation is a
follow-up or signifies the start of a new treatment. Con-
sidering that on an annual basis five primary care visits are
covered by the basic health insurance (one every
2.4 months), we assume primary mental healthcare ses-
sions to be initial treatments when taking place three or
more months after a previous primary care session. These
initial treatments are measured per 10,000 insured per
month. The number of initial treatments thus found, for
both types of mental healthcare, are roughly normally
distributed within years in our sample among both adults
and non-adults.
Methods
To evaluate the impact of copayments on mental healthcare
utilization, we analyze changes of the monthly number of
initial mental health treatments in our sample for both
adults who faced changes in copayments and non-adults
who did not face such changes. All analyses are performed
using IBM Statistical Package for the Social Sciences
(SPSS) version 23.0 for Windows. First, we perform paired
t tests for the number of monthly initial treatments between
the years 2011 and 2012 and 2012 and 2013 independently
for both initial primary and secondary mental healthcare
among non-adults and among adults. In addition, homo-
geneity of variance is tested by performing a Levene’s test
alongside all t tests. These are followed by a difference-in-
difference analysis between adults (treatment group) and
non-adults (control group) over these two periods of time,
using ordinary least squares (OLS) regression. We do so
according to the following equation:
YA;T ¼ aþ bA  Aþ bT  T þ bAT  A  Tð Þ þ A;T ð1Þ
This equation describes mental healthcare utilization (in
average number of monthly numbers of initial treatments)
(Y) as a function of adulthood (A) (minor = 0, adult = 1),
time (T) (2011 = 0, 2012 = 1 or 2012 = 0, 2013 = 1) and
time-differential adulthood effects, with error term  and
subject to parameters a and b. Subsequently, we analyze
changes in secondary care utilization by separating sec-
ondary mental healthcare by kind of disorder treated and by
duration of the treatment.
We expect to find significant changes in utilization for
adults in secondary mental healthcare, while such changes
are expected to be absent among non-adults. Although non-
adults and adults are not completely similar groups, there is
no reason to believe their mental healthcare utilization
trends are not similar ceteris paribus. The hypothesized
differential utilization trend would hence be attributable to
the introduction of copayments for adults only. We also
expect some impact of the copayments for primary care.
Possibly, these changes are smaller than in secondary
mental healthcare as the increase of copayments in primary
care is smaller. On the other hand, illnesses treated in
primary care are less serious than those treated in sec-
ondary care and are thus presumably easier to forego.
Second, we zoom in further on these effects by com-
paring the number of monthly initial mental healthcare
treatments with the annual mean. Subsequently, we com-
pare this with the annual standard error in order to analyze
anticipation effects. Lack of data from earlier years, as well
Table 1 Cost sharing for adult
mental healthcare between 2011
and 2013
Cost sharing 2011 2012 2013
Primary mental healthcare copayments €10a €20b €20b
Secondary mental healthcare copayments €0 €100/€200c €0
a With a maximum of 8 sessions covered annually
b With a maximum of 5 sessions covered annually
c €100 per 100 min of treatment capped at €200 annually
6 It is important to consider that relying on data provided by
healthcare providers has two consequences. First, around 66% of all
patients with a mental condition do not receive any treatment [20].
This group is not included in such data. Second, to an extent
healthcare providers have opportunities for upcoding, hence the DTC
codes can moderately deviate from the actual situation [21].
7 In the period studied, treatment duration was not reported directly.
Ranges of total duration of the diagnosis and treatment could be
inferred from the reported tariffs. For example, a fee of 3297 euros
could be matched to a treatment duration between 1800 and
3000 min.
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as converse effects of the introduction and repeal of
copayments prevent a more sophisticated analysis, cor-
recting for seasonality and annual trends. As anticipatory
behavior presupposes awareness of the policy changes
among the population, we have also tried to evaluate levels
of awareness. Figure 2 (see Appendix) gives an overview
of the utilization of related search terms in Google and
links this to events surrounding the development of the new
deductible policy and its repeal.
Third, we analyze to what extent differential effects of
copayments exist between men and women and between
different SES quintiles. To do so, we estimate the follow-
ing equations:
YG;T ¼ aþ bG  Gþ bT  T þ bGT  G  Tð Þ þ G;T ð2Þ
YSES;T ¼ aþ bSES  SESþ bT  T þ bSEST  SES  Tð Þ
þ SES;T : ð3Þ
These equations describe Y in a similar way as Eq. (1)
and as a function of: (2) gender (G) (male = 0,
female = 1), time (T) and time-differential gender effects;
and: (3) as a function of SES quintile (SES quintile A = 0,
SES quintile B = 1), time, and time-differential SES
quintile effects, respectively. We employ an OLS regres-
sion accordingly to estimate regression coefficients
between men and women as well as regression coefficient
between all pairs of SES quintiles.
Results
Paired t tests show that the monthly number of initial
secondary treatments for adults differs significantly
between consecutive years in the period 2011–2013.
Results of these tests are summarized in Table 2. In 2012,
the number of initial secondary treatments per 10,000
insured dropped with 11.72 initial treatments (35%),
compared to 2011 (p\ 0.01). As hypothesized, no signif-
icant changes are found for mental healthcare utilization
among non-adults. Neither are significant changes in initial
primary treatments utilization detected among adults;
t tests show only small and non-significant decreases in
initial primary visits between 2011–2012 and 2012–2013.
These results are robust and hold when the number of
initial treatments is measured per week or per 2 weeks
instead of per month. The variation in monthly number of
initial treatments moreover satisfies homoscedasticity.8 A
difference-in-difference analysis of the outpatient sec-
ondary mental healthcare utilization of adults and non-
adults over the same periods of time confirms these results.
This analysis reveals a significant (p\ 0.01) time-differ-
ential utilization change between adults and non-adults in
2012 as compared to 2011 (Table 3).
Focusing on the significant decrease in secondary care
utilization among adults in 2012, results display that uti-
lization decreased across many of the existing 15 diagnosis
codes. Table 4 shows t tests performed on the monthly
number of initial treatments by diagnosis code between
2011 and 2012. The results demonstrate that the relatively
strongest decreases in treatment utilization can be found
among ‘‘vague’’ diagnosis codes: ‘unknown diagnoses’,
‘group rest diagnoses’9 and ‘other conditions that may be a
cause for concern’. Additionally, the utilization of treat-
ments for ‘adjustment disorders’ seems to have evaporated
almost completely after the removal of these disorders
from the basic health insurance benefits package.10 More-
over, treatments for ‘alcohol-related disorders’ also
decreased significantly, highlighting the price responsive-
ness of these treatments.
Distinguishing by treatment duration, significant and
substantial decreases are found for short treatment dura-
tions between 2011 and 2012 as well as significant
increases in treatments of the shortest and the longest
duration in 2013. These results are summarized in Table 5.
Notably, when separated by duration, in 2013 we find
significant increases in utilization of treatments of
0–250 min and C6000 min in duration, while in general
there has been no significant increase in initial secondary
Table 2 Paired t tests for
monthly initial mental
healthcare treatments between
consecutive years
Years by type of care Adults Non-adults
Mean dif. t value p value Mean dif. t value p value
Primary care 2011–2012 -0.85 -0.95 0.36 0.11 0.48 0.64
2012–2013 -1.06 -1.50 0.15 -0.21 -0.76 0.45
Secondary care 2011–2012 -11.72 -9.65 0.00** 0.26 0.60 0.56
2012–2013 1.44 1.47 0.14 -0.24 -0.49 0.63
* p\ 0.05, ** p\ 0.01
8 Levene’s tests [22] have been performed alongside all t tests and
found no heteroscedasticity between any pair unless stated differently.
9 ‘Group rest diagnoses’ include DSM-IV diagnoses that have not
been assigned separate diagnosis codes such as disorders of impulse
control, dissociative disorders, and sexual and gender identity
disorders.
10 Exclusion of ‘adjustment disorders’ from the overall analyses
summarized in Tables 2 and 3 did not alter the interpretation of our
findings.
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treatments. Still, the increase in 2013 for initial secondary
treatments of 0–250 min of 0.75 per 10,000 insured does
not outweigh the 2012 decrease of 4.08 treatments. Finally,
it is important to note that treatments of shorter duration
are overrepresented among ‘‘vague’’ diagnosis codes.
Hence, decreases in treatment utilization seem concen-
trated among treatments with ‘‘vague’’ diagnosis codes,
treatments of short duration and among treatments that are
both of short duration and with a ‘‘vague’’ diagnosis code.
Concerning anticipatory behavior, Fig. 1 reveals sig-
nificant deviations from the annual mean of monthly
initial secondary treatments among adults at two points in
time: in December 2012 and in January 2013. Among
non-adults, the only significant deviation from an annual
mean is found in August 2013. This deviation seems to
signify an annually recurring decrease in utilization in
July and August that is especially prevalent among non-
adults: the summer break. In addition, we find a non-
significant increase in initial secondary treatments after
the announcement of copayments in June 2011 until the
introduction of copayments in January 2012. This
increase bears similarities with our proxy for awareness of
the introduction of copayment as summarized in Fig. 2
(see Appendix). Splitting these results by treatment
duration, we find that for treatments of 250–1800 min
there was a significant negative deviation in December
2012, and a significant positive deviation in January 2013.
For treatments of 1800–6000 min in duration, we find a
significant positive deviation in January 2013 and a neg-
ative deviation in December 2013. No other significant
deviations from the annual means have been discovered.
Hence, anticipation effects appear to be concentrated
among treatments of moderate duration.
Table 3 Standardized coefficients for average number of monthly
initial secondary mental healthcare treatments after OLS regression
Independent variable 2011–2012 2012–2013
b p value b p value
Adulthood (A) 1.16 0.00** 0.98 0.00**
Time (T) 0.00 0.99 -0.08 0.86
A  T -0.36 0.00** 0.01 0.92
*p\ 0.05, ** p\ 0.01
Table 4 Paired t tests for
monthly initial secondary
mental healthcare treatments by
diagnosis code between 2011
and 2012
Diagnosis code Mean dif. t value p value
Unknown diagnoses -8.79 -17.88 0.00**
Other disorders in childhood 0.02 1.50 0.13
Pervasive developmental disorders -0.13 -1.28 0.22
Attention deficit disorders and behavioral disorders -0.14 -1.63 0.12
Group rest diagnoses -1.56 -15.21 0.00**
Adjustment disorders -1.97 -6.28 0.00**a
Other conditions that may be a cause for concern -1.39 -7.18 0.00**
Delirium, dementia and amnestic and other cognitive disorders -0.05 -0.83 0.42
Alcohol-related disorders -0.31 -4.94 0.00**
Other disorders related to an agent -0.10 -1.19 0.24
Schizophrenia and other psychotic disorders -0.10 -0.99 0.33
Depressive disorders 0.81 1.63 0.12
Bipolar and other mood disorders 0.05 0.90 0.38
Anxiety disorders 1.09 1.35 0.19
Personality disorders 0.26 0.86 0.40
* p\ 0.05, ** p\ 0.01
a A Levene’s test found heteroscedasticity of variation
Table 5 Paired t tests of
monthly initial secondary
mental healthcare treatments by
duration
Treatment duration (min) 2011–2012 2012–2013
Mean dif. t value p value Mean dif. t value p value
0–250 -4.08 -16.60 0.00** 0.75 3.47 0.00**
250–1800 -10.62 -9.84 0.00** 0.08 0.07 0.95
1800–6000 0.20 0.53 0.50 0.76 1.94 0.07
C6000 0.04 0.70 0.49 0.18 2.29 0.03*
* p\ 0.05, ** p\ 0.01
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As for time-differential gender effects, we find that
women in general have higher levels of initial secondary
treatments, but that these levels decreased significantly
more than those of men from 2011 to 2012 (Table 6).
Hence, the introduction of copayments has decreased
mental healthcare utilization among men, but did so more
strongly for women, nearly equalizing the level of treat-
ment seeking in both groups. Thus, copayments did not
aggravate existing treatment inequalities between men and
women. Rather, such treatment inequalities seem to have
diminished in 2012, as especially women, who had previ-
ously been more likely to seek treatment, showed a larger
reduction in healthcare utilization (38 vs. 30%).
Examining time-differential effects between pairs of
SES quintiles, we find no indications of different changes
of healthcare utilization between the SES quintiles. All
SES quintiles show a mental healthcare utilization level of
37–44 initial treatments per 10,000 insured in 2011. In
2012, this dropped to 24–29 initial treatments, with
decreases in healthcare utilization among different SES
quintiles varying from 32% for the lowest quintile to
35–36% for all other quintiles. Similarly, the analyses do
not reveal significant time-differential effects between
pairs of SES quintiles. Possibly, these findings are impac-
ted by the use of aggregated SES scores to estimate indi-
vidual SES scores.
Conclusions
In this study, we examined the effects of changes in cost
sharing in both primary and secondary mental healthcare
in the Netherlands. We capitalized on the exemption of
non-adults from copayments to form a control group. We
employed t tests and OLS regressions to evaluate uti-
lization differences among different years, within sub-
groups, and between various treatments. This adds to the
existing copayment literature by estimating demand
response without selection effects and with a natural
control group.
First, our results show that the introduction of a sec-
ondary mental healthcare copayment of €200 was followed
by a 35% decrease in initial treatments among adults,
without selection effects. A similar decrease was absent
among non-adults. The impact of the copayments was
strongest among treatments of short duration and treat-
ments with ‘‘vague’’ diagnoses. This provides further evi-
dence that the way in which copayments affect healthcare
consumption depends partially on the necessity of care.
However, we find no changes in primary healthcare uti-
lization for milder care needs. Presumably, this is because
primary mental healthcare copayments were already in
place and were only increased with €10 per visit in 2012.
Second, our findings confirm the existence of anticipa-
tory behavior; in line with earlier research the data showed
increased mental healthcare utilization prior to the intro-
duction of copayments in 2012 and significantly reduced
initial treatments prior to the repeal of copayments in 2013.
This implies that the demand response excluding antici-
pation effects is lower than 35%. The anticipation effects
are concentrated among treatments of relatively short
duration, suggesting that anticipatory behavior is strongest
where general utilization effects are strongest and that both
effects vary with the necessity of care.
▲ Monthly number of initial treatments deviates two or more standard errors from the annual mean 
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Table 6 Standardized coefficients for average number of monthly
initial secondary mental healthcare treatments after OLS regression
Independent variable 2011–2012 2012–2013
b p value b p value
Gender (G) 0.92 0.00** 0.63 0.00**
Time (T) -0.37 0.00** -0.21 0.84
G  T -0.40 0.00** 0.20 0.84
* p\ 0.05, ** p\ 0.01
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Third, we find some evidence for a differential impact of
copayments: mental healthcare utilization decreased sig-
nificantly more among women (38%) than among men
(30%). We find no significant differences in utilization
changes between SES quintiles. Possibly, this is due to the
use of aggregated SES scores based on zip code to estimate
individual SES scores. Still, our findings show lower
decreases in healthcare utilization among groups that have
been identified as underutilizing mental healthcare by
existing research. Mental healthcare utilization decreased
significantly less among men than among women and
less—albeit not significantly—among the lowest SES
quintile compared to other SES quintiles.
It is important to be aware of the limitations of our study
when interpreting the results. We used data from one single
Dutch health insurer. Although utilization trends of its
insured are in line with national trends, it is possible that
this has influenced our results. Furthermore, a general
assumption of studies relying on healthcare provider data is
that providers register treatments accurately and in good
faith. In addition, our analysis evaluates mental healthcare
utilization trends by various partitions independently. As
we have noted, some correlation exists between these
variables and should be taken into account when inter-
preting our findings. Furthermore, we assumed that dif-
ferences in mental healthcare utilizations between the
different years analyzed are attributable to the introduction
and repeal of copayments. Yet, the increases in the annual
mandatory deductible may also have had a downward
effect on the demand for mental healthcare by adults in
2012 and 2013. This implies that the impact of the new
copayment scheme in 2012 has probably been overesti-
mated. The higher deductible could also partially explain
why mental healthcare utilization has not returned to its
pre-2012 level after the repeal of copayments in 2013.
Our results have important implications for policy-
makers both in the Netherlands and in other countries. We
find that copayments for secondary mental health signifi-
cant have a strong impact on mental healthcare utilization.
The utilization effects, moreover, are unevenly distributed
among the population, indicating that implementing
copayments may change the distribution of mental health
across a population. At the same time, the existence of
anticipatory behavior shows that policy changes concern-
ing health insurance coverage should be carefully imple-
mented. Finally, this research has not focused specifically
on evaluating costs and benefits of the implemented policy
nor on its mental health effects or (potential) long-term
effects, which hence remain fruitful areas for future
research.
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Appendix
See Table 7 and Fig. 2.
Table 7 Overview of the distribution of the sample over population
SES quintiles
SES quintiles (%) SES range Percentage of
total sample (%)
0–20 -5.93 to -0.48 29.3
20–40 -0.49 to 0.11 23.7
40–60 0.12 to 0.52 13.1
60–80 0.53 to 0.97 14.5
80–100 0.98 to 2.93 19.4
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been retrieved from Google
Trends [23]
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